TRIM2 and breast carcinoma: GPER-MAPK/ERK pathway activation also affected the interaction of TRIM2 and Bim, leading to ubiquitination-mediated degradation of Bim, which plays a key role in the apoptosis of tamoxifen-resistant breast cancer cells [70].